X4 Pharmaceuticals(XFOR) - 2024 Q3 - Earnings Call Presentation

3Q 2024 Business Update & Phase 2 Chronic Neutropenia Study Results November 13, 2024 Forward-Looking Statements This presentation including any printed or electronic copy of these slides, the talks given by the presenters, the information communicated during any delivery of the presentation and any question and answer sessions and any documents or materials distributed at or in connection with the presentation, contains forward-looking statements within the meaning of applicable securities laws, including ...